Femy stock news.

The public float for FEMY is 14.94M, and at present, short sellers hold a 8.64% of that float. On November 08, 2023, the average trading volume of FEMY was 9.89M shares. FEMY) stock’s latest price update. Femasys Inc (NASDAQ: FEMY) has seen a decline in its stock price by -3.08 in relation to its previous close of 1.30.

Femy stock news. Things To Know About Femy stock news.

Dec 1, 2023 · Femasys (FEMY) Short Interest Ratio and Volume 2023. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow. Important info on NVDA trade (Ad) 12 crew members are missing, 1 dead after a cargo ship sinks off a Greek island in stormy seas. Latest SEC filings for Femasys Inc. (FEMY). Entering text into the input field will update the search result belowDec 1, 2023 · Femasys Inc’s trailing 12-month revenue is $1.1 million with a % profit margin. Year-over-year quarterly sales growth most recently was -33.3%. Analysts expect adjusted earnings to reach $-0.940 per share for the current fiscal year. Femasys Inc does not currently pay a dividend. Dec 2, 2023 · Get Femasys Inc (FEMY.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments RTTNews. Nov. 15, 2023, 08:41 AM. (RTTNews) - PharmaCyte Biotech, Inc. (PMCB) has made a $5 million investment in Femasys, Inc. (FEMY), a biomedical company. Femasys offers a broad portfolio of in ...

LAS VEGAS, November 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) ("Femasys"), a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys offers a broad portfolio of in …A high-level overview of Femasys Inc. (FEMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Nov 8, 2023 · The public float for FEMY is 14.94M, and at present, short sellers hold a 8.64% of that float. On November 08, 2023, the average trading volume of FEMY was 9.89M shares. FEMY) stock’s latest price update. Femasys Inc (NASDAQ: FEMY) has seen a decline in its stock price by -3.08 in relation to its previous close of 1.30.

ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced the …Femasys (NASDAQ:FEMY) filed a prospectus related to the offer and resale by the selling stockholders of up to an aggregate of 18.11M shares of common stock This prospectus is not an offer to sell.Stock analysis for Femasys Inc (FEMY:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Learn. Analysis by Sector. A high-level overview of Femasys Inc. (FEMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, …With a year-over-year growth in debt of -79.53%, FEMASYS INC's debt growth rate surpasses only 2.53% of about US stocks. In terms of volatility of its share price, FEMY is more volatile than 94.29% of stocks we're observing. If you're looking for stocks that are quantitatively similar to FEMASYS INC, a group of peers worth examining would be ...

That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ...

We would like to show you a description here but the site won’t allow us.

This trend is expected to have continued in the to-be-reported quarter. The Zacks Consensus Estimate for Femasys’ sales in the third quarter of 2023 is pegged at $0.4 million. However, sales in ...At first glance it's a bit worrying to see that Femasys actually boosted its cash burn by 14%, year on year. The revenue growth of 4.2% gives a ray of hope, at the very least. In light of the data ...Femasys Inc. (NASDAQ: FEMY) secured a $6.85 million upfront investment from PharmaCyte Biotech, Inc. and other healthcare investors, providing a total cash runway of $23 million until the second half of 2025. This investment will support the commercialization of infertility-related products and the advancement of FemBloc, Femasys' lead product ...The public float for FEMY is 19.48M, and currently, short sellers hold a 2.20% ratio of that floaft. The average trading volume of FEMY on November 24, 2023 was 10.08M shares. FEMY’s Market Performance. FEMY’s stock has seen a -9.52% decrease for the week, with a -26.31% drop in the past month and a 141.36% gain in the past quarter.With 11.8mil shares outstanding and a share price of $7.5, the market cap of Femasys is $88.5mil and with a cash position of $33mil, the enterprise value of the company is expected to be $55.5mil ...Oct 3, 2023 · FEMY Femasys Inc Form 8-K - Current report. Pursuant to the Equity Distribution Agreement, sales of the Shares, will be made under the Company’s previously filed and effective Registration Statement on Form S-3 (File No. 333-266001) and an applicable prospectus supplement, by any method that is deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act ... At first glance it's a bit worrying to see that Femasys actually boosted its cash burn by 14%, year on year. The revenue growth of 4.2% gives a ray of hope, at the very least. In light of the data ...

Find the latest Femasys Inc. (FEMY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Get the latest Femasys Inc. (FEMY) stock news and headlines to help you in your trading and investing decisions.Maxim Group analyst Jason McCarthy has maintained their bullish stance on FEMY stock, giving a Buy rating today.. Jason McCarthy’s Buy rating for Femasys (FEMY) is influenced by several factors ...FEMY | Complete Femasys Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. By Eddie Pan, InvestorPlace Financial News Writer Sep 29, 2023, 12:18 pm EST. The cost to borrow T2 Biosystems ( TTOO) tallies in at 37.62%, compared to 16.06% on Sept. 18. Meanwhile, 10% owner CR ...

Find the latest Femasys Inc. (FEMY) stock quote, history, news and other vital information to help you with your stock trading and investing.

It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...SeaStar Medical ( NASDAQ: ICU) said it has received an Approvable Letter from the FDA for its Selective Cytopheretic Device Pediatric, or SCD-PED, for use in children with acute kidney injury and ...LAS VEGAS, November 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) ("Femasys"), a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys offers a broad portfolio of in …Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Find the latest CISO Global Inc. (CISO) stock quote, history, news and other vital information to help you with your stock trading and investing.Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late ...FEMY Stock Price Prediction News Today 2 DecemberWith a year-over-year growth in debt of -79.53%, FEMASYS INC's debt growth rate surpasses only 2.53% of about US stocks. In terms of volatility of its share price, FEMY is more volatile than 94.29% of stocks we're observing. If you're looking for stocks that are quantitatively similar to FEMASYS INC, a group of peers worth examining would be ...See the latest Femasys Inc stock price (FEMY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Nov 14, 2023 · The average trading volume of FEMY on November 14, 2023 was 9.91M shares. FEMY) stock’s latest price update. Femasys Inc (NASDAQ: FEMY)’s stock price has decreased by -14.75 compared to its previous closing price of 1.22. However, the company has seen a -20.00% decrease in its stock price over the last five trading sessions.

PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (Femasys), a biomedical company focused on meeting... Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update Globe Newswire • 16 days ago.

Sep 25, 2023 · The stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ... Latest SEC filings for Femasys Inc. (FEMY). Entering text into the input field will update the search result belowWith stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Femasys Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Nov 14, 2023 · The average trading volume of FEMY on November 14, 2023 was 9.91M shares. FEMY) stock’s latest price update. Femasys Inc (NASDAQ: FEMY)’s stock price has decreased by -14.75 compared to its previous closing price of 1.22. However, the company has seen a -20.00% decrease in its stock price over the last five trading sessions. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre ...View the latest Femasys Inc. (FEMY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the latest dividend history for Femasys Inc. Common Stock (FEMY) at Nasdaq.com.On October 2, 2023, FEMY stock experienced significant fluctuations in its performance. The stock had a previous close of $3.01 and opened at $4.59. Throughout the trading day, the stock’s price ranged between $3.30 and $4.75. The volume of shares traded was 1,847,820. FEMY, a company operating in the Electronic Equipment/Instruments industry ...FEMY - Femasys Inc Stock Price and Quote. Nov-23-23 03:38PM. 20 Countries with the Highest Teenage Pregnancy Rates. (Insider Monkey) Nov-15-23 08:30AM. PharmaCyte Biotech Acquires $5 Million Stake in Emerging Womens Health Innovator Femasys, Inc. Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by ... Femasys Inc (NASDAQ:FEMY) trade information. Femasys Inc (FEMY) registered a -2.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.33% in intraday trading to $0.93 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -9.71%, and it has moved by -33.09% in ...AIM ImmunoTech Inc. 0.47. -0.002. -0.4237%. Get Femasys Inc (FEMY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Oct 2, 2023 · Recent News. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-market session. It has soared by over 1,257% from the lowest level in September, giving it a market cap of nearly $50 million. AIM ImmunoTech Inc. 0.47. -0.002. -0.4237%. Get Femasys Inc (FEMY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Sep 25, 2023 · ATLANTA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ... U.S.: Nasdaq. Add to Watchlist. 0.00. FEMY. Real Time Quote. About Femasys Inc. Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive ...Instagram:https://instagram. fagabellaintercept nashgood penny stock investmentsibond rate may 2023 Find the latest Femasys Inc. (FEMY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ... robinhood short selldividend and yield At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Femasys Inc. (NASDAQ: FEMY) appoints Dr. James Liu, M.D., a renowned figure from a top-ranked academic gynecology program, as Chief Medical Officer. Dr. Liu's appointment comes as Femasys accelerates the commercialization of its product pipeline, including a new therapeutic for artificial insemination, FemaSeed®. With significant … growgen auburn Femasys (NASDAQ: FEMY) stock price has made a strong comeback in the past few days as investors cheer the company’s FDA news.The shares surged to a high of $1.71, the highest level since October ...We would like to show you a description here but the site won’t allow us.Sep 26, 2023 · That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ...